XML 41 R22.htm IDEA: XBRL DOCUMENT v3.20.1
Stock-Based Compensation (Tables)
 3 Months Ended
May 02, 2020
Share-based Payment Arrangement [Abstract]  
Schedule of Compensation Costs
The compensation costs that have been charged against income for the 13-weeks ended May 2, 2020 and May 4, 2019 were as follows (in thousands):

13-Weeks Ended
May 2,
2020		May 4,
2019
Stock-based compensation expense by type:
Stock options
$90  $92  
Restricted stock units1,060  363  
Employee stock purchases
44  29  
Director deferred compensation23  23  
  Total stock-based compensation expense1,217  507  
Income tax benefit recognized391  113  
  Stock-based compensation expense, net of income tax$826  $394  
Schedule of Equity Awards Granted
In the 13-weeks ended May 2, 2020 and May 4, 2019, we granted the following equity awards:

13-Weeks Ended
May 2,
2020		May 4,
2019
Stock options
27,000  16,798  
Restricted stock unit awards
334,485  191,021  
Performance-based restricted stock unit awards
—  34,300  
Deferred stock units
2,143  1,027  
Schedule of Shares Purchased
The number of shares purchased, the average price per share and the weighted-average grant date fair value of shares purchased through our employee stock purchase plan were as follows:
13-Weeks Ended
May 2,
2020		May 4,
2019
Shares purchased17,758  9,925  
Average price per share$9.29  $12.16  
Weighted average fair value at grant date$4.21  $3.14